Get App Open
In App
Credit Cards
Open App
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 01, 16:01
1953.35 0.65 (0.03%)
Volume
AVERAGE VOLUME
5-Day
21,261
10-Day
26,739
30-Day
20,867
8,175
  • Prev. Close

    1952.70

  • Open Price

    1942.25

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 01, 15:50
1959.20 6.50 (0.33%)
Volume
AVERAGE VOLUME
5-Day
697,288
10-Day
697,890
30-Day
727,554
524,801
  • Prev. Close

    1952.70

  • Open Price

    1952.70

  • Bid Price (Qty.)

    1959.20 (1)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Glenmark Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 9,010.54 7,649.76 8,019.67 8,017.38 7,450.91  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 9,010.54 7,649.76 8,019.67 8,017.38 7,450.91  
Total Operating Revenues 9,226.41 7,891.12 8,220.66 8,141.58 7,567.93  
Other Income 356.37 1,168.02 985.94 614.63 396.24  
Total Revenue 9,582.78 9,059.14 9,206.60 8,756.21 7,964.17  
EXPENSES  
Cost Of Materials Consumed 2,781.45 2,990.41 3,035.88 2,993.04 2,678.26  
Purchase Of Stock-In Trade 373.21 322.78 391.19 481.62 315.96  
Operating And Direct Expenses 48.30 47.55 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade 44.48 -103.07 -31.37 -16.13 5.24  
Employee Benefit Expenses 1,603.50 1,434.78 1,346.51 1,193.20 1,107.40  
Finance Costs 48.73 277.11 206.82 236.04 265.90  
Depreciation And Amortisation Expenses 218.63 202.16 184.15 159.70 150.82  
Other Expenses 2,131.31 1,957.01 2,005.68 1,801.64 1,570.74  
Total Expenses 7,249.59 7,128.73 7,138.86 6,849.10 6,094.31  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,333.18 1,930.42 2,067.74 1,907.11 1,869.87  
Exceptional Items -179.17 5,070.33 -495.87 430.33 73.89  
Profit/Loss Before Tax 2,154.02 7,000.75 1,571.87 2,337.45 1,943.76  
Tax Expenses-Continued Operations  
Current Tax 316.09 1,049.99 386.93 411.08 343.62  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 227.58 783.46 -23.83 -71.42 -49.31  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 543.67 1,833.46 363.11 339.66 294.31  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,610.35 5,167.29 1,208.77 1,997.79 1,649.45  
Profit/Loss From Continuing Operations 1,610.35 5,167.29 1,208.77 1,997.79 1,649.45  
Profit/Loss For The Period 1,610.35 5,167.29 1,208.77 1,997.79 1,649.45  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 57.07 183.13 42.84 70.80 58.46  
Diluted EPS (Rs.) 57.07 183.13 42.84 70.80 58.46  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 70.55 70.54 70.54 70.54 70.54  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 250.00 250.00 250.00 250.00 250.00  
Source : Dion Global Solutions Limited

Results of Glenmark